Paper - WANFANG MED ONLINE

You Position: Home > Paper

Neonatal carnitine?acylcarnitine translocase deficiency in newborn:clinical features and gene mutation

( views:1323, downloads:288 )

Author:: No author available

Journal Title:: Chinese Journal of Biomedical Engineering

Issue:: 2

DOI:: 10.3760/cma.j.issn.1674-1927.2019.02.001

Key Word:: 脂肪酸氧化障碍;肉碱酰基肉碱转位酶;SLC25A20;婴儿,新生;Fatty acid oxidation disorder;Carnitine acylcarnitine translocase;SLC25A20;Infant,newborn

Abstract： Objective To investigate the clinical features of carnitine?acylcarnitine translocase deficiency (CACTD) and mutation of the gene SLC25A20 (solute carrier family126 25 member 20) in newborn. Methods The clinical features of a newborn with CACTD were analyzed. Mass spectrometry was used to detect the blood acylcarnitine and urine organic acid metabolites in the child. Sanger direct sequencing was used to detect the 9 exons of SLC25A20 gene in the child and his parents. The CNKI, Wanfang and PubMed databases were retrieved. The clinical features and gene mutation loci in CACTD neonates reported in China and worldwide were compared. Results In this male patient,CACTD occurred hours after birth,presenting cyanosis,malignant arrhythmia,cardiac arrest,convulsion,hypoketotic hypoglycemia,hyperammonemia,and hyperlactosis. Head magnetic resonance showed signs of metabolic encephalopathy. His blood acylcarnitine tested a low level of free carnitine and a high level of long?chain acylcarnitine. Gene sequencing showed that the patient was a homozygous mutant,and both of his parents were heterozygous mutants,for carnitine SLC25A20 c. 199?10T>G. A total of 41 known pathogenic mutations of the SLC25A20 gene were reported in the literature,with the c. 199?10T>G mutation commonly seen in East Asia. So far 12 CACTD patients with c. 199?10T>G mutation have been reported,all identified early in neonates, clinically manifested by cardiac arrest, respiratory failure, convulsion, feeding difficulties,and with high mortality rate. Conclusion Early onset and rapid deterioration of arrhythmia, hypoglycemia,hyperlactosis,and convulsions in newborns should highly alert for a probable diagnosis of CACTD or other fatty acid oxidation disorders,and prompt for timely testing of blood acylcarnitine,urine gas chromatography?mass spectrometry(GC?MS),and carnitine SLC25A20 gene profiling in order to make a clear diagnosis.

Reference

[1]严莉,张永庆,焦劲松,等.脂肪酸氧化代谢障碍研究进展[J].2006,(4).
[2]L. IJlst,C.W.T. van Roermund,V. Iacobazzi,etc.Functional Analysis of Mutant Human Carnitine Acylcarnitine Translocases in Yeast[J].2001,280(3).
[3]Vittoria Infantino,Lara Console,Nicola Giangregorio,etc.The mitochondrial carnitine/acylcarnitine carrier: function, structure and physiopathology.[J].2011,32(4).
[4]Robert S Y, Lee,C W, Lam,C K, Lai,etc.Carnitine-acylcarnitine translocase deficiency in three neonates presenting with rapid deterioration and cardiac arrest.[J].2007,13(1).
[5]Rubio Gozalbo ME,Wanders RJ,Bakker JA,etc.Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects.[J].2004,25(5).
[6]Kaneoka,H.,Sasaguri,Y.,Tokuyasu,T.,etc.Three novel mutations in the carnitine-acylcarnitine translocase (CACT) gene in patients with CACT deficiency and in healthy individuals[J].2013,58(12).
[7]Fearing MK,Rapalino O,Lisovsky M,etc.Case records of the Massachusetts General Hospital. Case 12-2011. A 9-month-old boy with acute liver failure.[J].2011,364(16).
[8]Morris AA,Turnbull DM,Jones RA,etc.A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype (see comments)[J].1998,132(3 Pt.1).
[9]Santer R,Spiekerkoetter U,Lindner M.Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop.[J].2009,32(4).
[10]Isidro, Vitoria,Elena, Martín-Hernández,Luis, Pe?a-Quintana,etc.Carnitine-acylcarnitine translocase deficiency: experience with four cases in Spain and review of the literature.[J].2015,20.
[11]A. Ogawa,S. Yamamoto,M. Kanazawa,etc.Identification of two novel mutations of the carnitine/acylcarnitine translocase (CACT) gene in a patient with CACT deficiency[J].2000,45(1).
[12]Chalmers RA,Ganguly A,Hsu BY,etc.Aberrant mRNA splicing associated with coding region mutations in children with carnitine-acylcarnitine translocase deficiency.[J].2001,74(1).
[13]English N,Wigglesworth JS,Stanley CA,etc.Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death.[J].1997,131(2).
[14]Zater M,Gutman A,Pitt JJ,etc.A novel SLC25A20 splicing mutation in patients of different ethnic origin with neonatally lethal carnitine-acylcarnitine translocase (CACT) deficiency.[J].2006,89(4).
[15]Wanders RJ,Ruiter JP,IJLst L,etc.The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results.[J].2010,33(5).
[16]Mallory JM,Ding JH,Jones KM,etc.Carnitine/acylcarnitine translocase deficiency (neonatal phenotype): successful prenatal and postmortem diagnosis associated with a novel mutation in a single family.[J].2001,73(1).
[17]Hui-Ming, Yan,Hao, Hu,Aisha, Ahmed,etc.Carnitine-acylcarnitine translocase deficiency with c.199-10 T>G and novel c.1A>G mutation: Two case reports and brief literature review.[J].2017,96(45).
[18]C A, Stanley,D E, Hale,G T, Berry,etc.Brief report: a deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane.[J].1992,327(1).
[19]Vatanavicharn, Nithiwat,Yamada, Kenji,Aoyama, Yuka,etc.Carnitine-acylcarnitine translocase deficiency: Two neonatal cases with common splicing mutation and in vitro bezafibrate response[J].2015,37(7).
[20]Marjan Huizing,Vito Iacobazzi,Lodewijk IJlst,etc.Cloning of the Human Carnitine-Acylcarnitine Carrier cDNA and Identification of the Molecular Defect in a Patient[J].1997,61(6).
[21]Vito Iacobazzi,Federica Invernizzi,Silvia Baratta,etc.Molecular and functional analysis of <em>SLC25A20</em> mutations causing carnitine-acylcarnitine translocase deficiency[J].2004,24(4).
[22]Slama A,Costa JM,Vequaud C,etc.Mutational spectrum and DNA-based prenatal diagnosis in carnitine-acylcarnitine translocase deficiency.[J].2003,78(1).
[23]Birk OS,Moses SW,Hershkovitz E,etc.Carnitine-acylcarnitine translocase deficiency: Identification of a novel molecular defect in a Bedouin patient.[J].2004,27(2).
[24]Douglas G,Browning M,Wang J,etc.Expanded molecular features of carnitine acyl-carnitine translocase (CACT) deficiency by comprehensive molecular analysis.[J].2011,103(4).
[25]A. I Al Aqeel,M. S Rashid,J. Pn Ruiter,etc.A novel molecular defect of the carnitine acylcarnitine translocase gene in a Saudi patient[J].2003,64(2).